PARP/EZH2-IN-1
| Code | Size | Price |
|---|
| TAR-T40310-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
PARP/EZH2-IN-1 is a first-in-class dual PARP ( IC 50 6.87 nM) and EZH2 ( IC 50 36.51 nM) inhibitor for triple-negative breast cancer with wild-type BRCA.
CAS:
2687273-52-3
Formula:
0
Molecular Weight:
0
Purity:
0.98
SMILES:
0
References
Wang C, et al. Discovery of First-in-Class Dual PARP and EZH2 Inhibitors for Triple-Negative Breast Cancer with Wild-Type BRCA. J Med Chem. 2021 Sep 9;64(17):12630-12650.